How many 8-K filings has Clearpoint Neuro, Inc. filed?

Clearpoint Neuro, Inc. (CLPT) has 10 8-K (Current Event Report) filings on record, spanning Jan 2024 to Nov 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Clearpoint Neuro, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Clearpoint Neuro, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Clearpoint Neuro, Inc. (CLPT) — 8-K Filings

All 8-K filings from Clearpoint Neuro, Inc.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

8-K Filing — Nov 20, 2025
ClearPoint Neuro Enters Material Definitive Agreement — Jun 17, 2025 Risk: medium
ClearPoint Neuro, Inc. announced on June 16, 2025, that it has entered into a material definitive agreement. The company, formerly known as MRI Interventions, I
ClearPoint Neuro Files 8-K on Officer Changes and Shareholder Votes — May 23, 2025 Risk: low
ClearPoint Neuro, Inc. filed an 8-K on May 23, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain
ClearPoint Neuro Files 8-K — May 19, 2025 Risk: low
ClearPoint Neuro, Inc. filed an 8-K on May 19, 2025, reporting other events and financial statements. The company, formerly known as MRI Interventions, Inc., is
ClearPoint Neuro Enters Material Definitive Agreement — May 12, 2025 Risk: medium
ClearPoint Neuro, Inc. announced on May 12, 2025, that it has entered into a material definitive agreement. The company, formerly known as MRI Interventions, In
ClearPoint Neuro Enters Material Definitive Agreement — Nov 7, 2024 Risk: medium
ClearPoint Neuro, Inc. announced on November 7, 2024, that it has entered into a material definitive agreement. The company, formerly known as MRI Interventions
ClearPoint Neuro to be Acquired by RTW Master Fund Affiliate — Aug 26, 2024 Risk: medium
ClearPoint Neuro, Inc. announced on August 26, 2024, that it has entered into a definitive agreement to be acquired by an affiliate of RTW Master Fund Ltd. The
ClearPoint Neuro Appoints New CMO, Elects Directors — May 16, 2024 Risk: low
ClearPoint Neuro, Inc. announced on May 16, 2024, the appointment of Dr. Steven J. Shagan as Chief Medical Officer and the election of Dr. Shagan and Ms. Jennif
ClearPoint Neuro Enters Material Definitive Agreement — Mar 1, 2024 Risk: medium
ClearPoint Neuro, Inc. announced on March 1, 2024, that it entered into a Material Definitive Agreement on February 28, 2024. The filing also includes financial
ClearPoint Neuro Files 8-K on Operations & Financial Condition — Jan 8, 2024
ClearPoint Neuro, Inc. filed an 8-K on January 8, 2024, to report on its financial condition and operations. This filing is a standard disclosure, indicating th

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX